Horizon 2020 New Deal project for treatment of inflammatory bowel diseases
Boyds has been working with New Deal and a team of European partners on a nanotherapy research project into the treatment of inflammatory bowel diseases. In Europe, over two million people are affected by ulcerative colitis or Crohn’s disease, conditions that are characterised by an inflammation of the bowel (Inflammatory bowel diseases). They occur when cells from […]
Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine From a UK Perspective
Professor Alan Boyd has co-authored a paper which looks at ethical principles in the practice of pharmaceutical medicine, published this month in Frontiers in Pharmacology. The paper, ‘Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine from a UK Perspective’ looks at how pharmaceutical medicine has evolved to be a distinct medical scientific discipline. […]
Boyds scoop Business of the Year at South Cheshire Chamber Awards
Boyds took away the award for Business of the Year (under 25 employees) at the 2019 South Cheshire Chamber of Commerce Business Awards. The annual Awards bring together the South Cheshire business community, showcasing the achievements of a range of businesses and talented individuals. Now in their 23rd year, the Business Awards recognise everything that […]
Boyds Regulatory Team Crowned Winner at 2019 TOPRA Awards
Boyds’ regulatory affairs team won the Futures category at this year’s TOPRA Awards in recognition for its work in cell and gene therapies. The TOPRA Awards for Regulatory Excellence were established in 2010 to reward excellence in regulatory affairs and to recognise the achievement of individuals, teams and organisations both within TOPRA and in the […]
Sabine Ruehle presents at BIA UK Bioscience Forum 2019 – slides now available
Sabine Ruehle, Regulatory Affairs Senior Associate at Boyds, presented at the BIA UK Bioscience Forum 2019 in October at County Hall in Westminster. Sabine’s talk on “Bench to bedside: preclinical considerations for advanced therapies” explored what is needed from the regulatory and safety perspective for the preclinical work to support the administration of ATMPs to […]
Boyds shortlisted as finalist in South Cheshire Chamber Business Awards 2019
Boyds joins the list of finalists for this year’s South Cheshire Chamber of Commerce Business Awards. The Awards bring together the business community in South Cheshire, showcasing the achievements of a range of businesses and talented individuals. Now entering their 23rd year, the Business Awards recognise everything that is great and good about business in […]
Julie Warner awarded TOPRA Distinguished Service Award
Julie Warner, Director of Regulatory Affairs at Boyds, has been awarded the TOPRA Distinguished Service Award. This award recognises volunteers whose contributions have made a real difference to TOPRA and the profession. Julie received the award following a recommendation from one of her peers as well as endorsement from the TOPRA Board. In particular, this […]
Chariots of Fire
Members of the Boyds team in Cambridge and friends, completed the Chariots of Fire run in Cambridge last month. Chariots of Fire is one of Cambridgeshire’s largest annual charity events and took place on the 22 September 2019. Teams of six each run a 1.7 mile course in relay format. The event is organised and […]
Boyds strengthens expertise with key appointment of Susan Tansey
Boyds is delighted to welcome Susan Tansey who joins the business as Consultant Pharmaceutical Physician. Dr Tansey joins Boyds with more than 20 years’ experience in rare disease clinical trials. A paediatrician specialising in respiratory paediatrics and neonatology, Susan joined the pharmaceutical industry in 1998 and has worked in clinical development across several therapeutic areas, […]
Boyds acquires Blue Duck Consultancy Ltd
Boyds has enhanced its clinical and medical affairs services offering following the acquisition of Blue Duck Consulting. Since 2013, Blue Duck has provided expert preclinical and clinical drug development strategies and specialist monitoring and project management of clinical operations services in a range of therapeutic areas, led by its founder Dr Karen O’Hanlon, who joins […]
